Foreign investors divested ₹4,521 crore from IT and ₹4,036 crore from healthcare stocks in the latter half of September. This selling was driven by concerns over US H-1B visa restrictions and new pharma tariffs, impacting export-oriented sectors. Overall, FPIs sold ₹19,647 crore across 15 sectors (...)
Site référencé: The Economic Times
The Economic Times
Fixed income set to perform well amid limited easing room, says Churchil Bhatt
9/10/2025
Explained : Reliance Industries is India’s most valuable company but why isn’t it No.1 in Nifty50 weight ?
9/10/2025
What we know about the new Gaza deal
9/10/2025
These numbers show how 2 years of war have devastated Palestinian lives in Gaza
9/10/2025
Asian shares rise after US gains driven by AI-linked companies
9/10/2025
Can Rubicon Research sustain its impressive growth while facing US market risks ?
9/10/2025
